Physician profile
Chandra Marea Miller
NPI 1124098140
$1,481.39
in general payments reported to CMS, 2019-2025
17 companies · $243 in 2025
The $243 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $173 · 2021: $231 · 2022: $132 · 2023: $222 · 2024: $326 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $328.22 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $163.42 | 2021-2025 | Qelbree |
| Sobi, INC | $147.07 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $146.64 | 2019-2023 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $119.92 | 2019-2021 | |
| Sanofi Pasteur INC. | $117.04 | 2021-2025 | |
| Glaxosmithkline, LLC. | $104.45 | 2020-2024 | Bexsero, Menveo, Pediarix |
| Sanofi-Aventis U.S. LLC | $72.78 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $52.69 | 2019-2024 | Gardasil 9, Vaxelis, Gardasil |
| Adlon Therapeutics L.P. | $41.99 | 2020-2021 | |
| Avion Pharmaceuticals | $40.39 | 2023 | Methylphenidate Hydrochloride |
| Collegium Pharmaceutical, INC. | $32.62 | 2025 | Jornay Pm |
| Abbott Laboratories | $32.22 | 2019 | |
| Pfizer INC. | $29.12 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $21.53 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.50 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.79 | 2024 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandra Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.